Gsa Capital Partners LLP Ideaya Biosciences, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.19 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$13.49 - $18.72 $224,217 - $311,145
16,621 New
16,621 $228,000
Q2 2022

Aug 09, 2022
SELL
$8.28 - $13.88 $448,900 - $752,504
-54,215 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$11.18 - $24.02 $446,663 - $959,647
39,952 Added 280.11%
54,215 $607,000
Q4 2021

Feb 14, 2022
BUY
$20.95 - $26.88 $298,809 - $383,389
14,263 New
14,263 $337,000

Others Institutions Holding IDYA

# of Institutions
206
Shares Held
71.2M
Call Options Held
29.8K
Put Options Held
8.5K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.6B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email